Episodic status migrainosus: A novel migraine subtype

被引:14
|
作者
Singh, Tarun D. [1 ,2 ]
Cutrer, F. Michael [1 ]
Smith, Jonathan H. [2 ]
机构
[1] Mayo Clin, Dept Neurol, Rochester, MN USA
[2] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA
关键词
Migraine; status migrainosus; episodic status migrainosus; chronic migraine; headache; depression; TERTIARY-CARE; PREVALENCE; OSMOPHOBIA; DISEASE; BURDEN;
D O I
10.1177/0333102416686341
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To report a case series of a novel migraine subtype, which we term as episodic status migrainosus (ESM), characterized by attacks of migraine exclusively lasting more than 72 hours. We hypothesized that this would represent a novel nosologic entity, possibly an unstable migraine phenotype with a high conversion rate to chronic migraine (CM). Methods We conducted a retrospective review of patients diagnosed with status migrainosus at the Mayo Clinic, Rochester, between January 2005 and December 2015. All the records were then manually reviewed for patients with migraine headaches exclusively lasting more than 72 hours. Results We identified 18 patients with ESM, with a female predominance (15(83.3%)) and a median age of onset of 16.5 (IQR 13-19) years. The median monthly attack frequency was two (IQR 1-3), with each attack lasting a median duration of seven (IQR 4-12.5) days. Stress was the most commonly reported precipitant (11 (61.1%)). Migraine with aura was common (10 (55.6%)), as was comorbid depression (10 (55.6%)). Fifteen (83.3%) patients developed CM at a median of 7.8 (IQR 2.6-21.9) years from their first attack. There was no significant association between the time to the development of chronic migraine with either attack frequency or duration. Conclusions and relevance We report the existence of a novel migraine subtype, episodic status migrainosus. This migraine subtype appears to have similar clinical characteristics to episodic migraine with or without aura, except for a notably high tendency to progress to chronic migraine.
引用
下载
收藏
页码:304 / 311
页数:8
相关论文
共 50 条
  • [21] Optic neuritis and status migrainosus
    Lee, Yong-Seok
    CEPHALALGIA, 2007, 27 (06) : 704 - 705
  • [22] Cardiovascular And Cerebrovascular Disease Risk Assessment Amongst Patients With Status Migrainosus And Migraine With Aura - A Nationwide Study
    Shah, Dhaivat
    Patel, Kulin
    Pathak, Stuti
    Nadella, Adithya
    Shah, Khushboo
    Shelar, Vrushali
    Sundararaju, Ponrasu
    Somi, Shamima A.
    Pelidis, Michael
    Igbenabor, Christiana
    Vimalathithan, Vinith
    Charishma, Sabbineni
    Thompson, Chadane
    Patel, Urvish K.
    Belletieri, Christopher
    STROKE, 2023, 54
  • [23] PRACTICE PARAMETER - APPROPRIATE USE OF ERGOTAMINE TARTRATE AND DIHYDROERGOTAMINE IN THE TREATMENT OF MIGRAINE AND STATUS MIGRAINOSUS - SUMMARY STATEMENT
    ALTER, M
    BYRNE, TN
    DAUBE, J
    FRANKLIN, G
    GOLDSTEIN, ML
    GREENBERG, MK
    LANSKA, DJ
    MISHRA, S
    ODENHEIMER, GL
    PAULSON, G
    PEARL, RA
    ROSENBERG, JH
    STEVENS, J
    NEUROLOGY, 1995, 45 (03) : 585 - 587
  • [24] Novel Findings within Basal Ganglia in Episodic Migraine
    Maleki, N.
    Nutile, L.
    Pendse, G.
    Bigal, M.
    Burstein, R.
    Becerra, L.
    Borsook, D.
    HEADACHE, 2011, 51 : 5 - 5
  • [25] Episodic Migraine
    Wiebrecht, Axel
    DEUTSCHE ZEITSCHRIFT FUR AKUPUNKTUR, 2019, 62 (02): : 143 - 143
  • [26] Pituitary Apoplexy Presenting as Status Migrainosus
    Shabas, Debra
    Sheikh, Huma U.
    Gilad, Ronit
    HEADACHE, 2017, 57 (04): : 641 - +
  • [27] SHIFT FROM CHRONIC TO EPISODIC MIGRAINE STATUS AND HIGH- TO LOW-FREQUENCY EPISODIC MIGRAINE STATUS AMONG PATIENTS WITH TREATMENT-RESISTANT MIGRAINE IN A PHASE 3 GALCANEZUMAB STUDY
    Day, Kathleen A.
    Rettiganti, Mallik
    Ferguson, Margaret B.
    Stroud, Chad E.
    Trewin, Benjamin P.
    Takeshima, Takao
    Kingston, William S.
    CEPHALALGIA, 2020, 40 : 75 - 75
  • [28] Methylprednisolone for Status Migrainous Vertigo and Cephalic Status Migrainosus
    Robbins, Matthew S.
    Wang, Dong
    DeOrchis, Vincent S.
    HEADACHE, 2010, 50 (02): : 328 - 328
  • [29] Understanding Cutaneous Allodynia in Status Migrainosus
    Pellegrino, Walters A.
    Rich-Fiondella, R.
    Grosberg, B. M.
    Burstein, R.
    HEADACHE, 2018, 58 : 112 - 112
  • [30] Intravenous valproate sodium for status migrainosus
    Krusz, JC
    ANNALS OF NEUROLOGY, 2004, 56 : S52 - S52